Literature DB >> 9784530

Disruption of an internal membrane-spanning region in Shiga toxin 1 reduces cytotoxicity.

M L Suhan1, C J Hovde.   

Abstract

Shiga toxin type 1 (Stx1) belongs to the Shiga family of bipartite AB toxins that inactivate eukaryotic 60S ribosomes. The A subunit of Stxs are N-glycosidases that share structural and functional features in their catalytic center and in an internal hydrophobic region that shows strong transmembrane propensity. Both features are conserved in ricin and other ribosomal inactivating proteins. During eukaryotic cell intoxication, holotoxin likely moves retrograde from the Golgi apparatus to the endoplasmic reticulum. The hydrophobic region, spanning residues I224 through N241 in the Stx1 A subunit (Stx1A), was hypothesized to participate in toxin translocation across internal target cell membranes. The TMpred computer program was used to design a series of site-specific mutations in this hydrophobic region that disrupt transmembrane propensity to various degrees. Mutations were synthesized by PCR overlap extension and confirmed by DNA sequencing. Mutants StxAF226Y, A231D, G234E, and A231D-G234E and wild-type Stx1A were expressed in Escherichia coli SY327 and purified by dye-ligand affinity chromatography. All of the mutant toxins were similar to wild-type Stx1A in enzymatic activity, as determined by inhibition of cell-free protein synthesis, and in susceptibility to trypsin digestion. Purified mutant or wild-type Stx1A combined with Stx1B subunits in vitro to form a holotoxin, as determined by native polyacrylamide gel electrophoresis immunoblotting. StxA mutant A231D-G234E, predicted to abolish transmembrane propensity, was 225-fold less cytotoxic to cultured Vero cells than were the wild-type toxin and the other mutant toxins which retained some transmembrane potential. Furthermore, compared to wild-type Stx1A, A231D-G234E Stx1A was less able to interact with synthetic lipid vesicles, as determined by analysis of tryptophan fluorescence for each toxin in the presence of increasing concentrations of lipid membrane vesicles. These results provide evidence that this conserved internal hydrophobic motif contributes to Stx1 translocation in eukaryotic cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9784530      PMCID: PMC108656     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

1.  Nucleotide sequence of the Shiga-like toxin genes of Escherichia coli.

Authors:  S B Calderwood; F Auclair; A Donohue-Rolfe; G T Keusch; J J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

2.  Evidence that the A2 fragment of Shiga-like toxin type I is required for holotoxin integrity.

Authors:  P R Austin; P E Jablonski; G A Bohach; A K Dunker; C J Hovde
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

3.  A hydrophobic region of ricin A chain which may have a role in membrane translocation can function as an efficient noncleaved signal peptide.

Authors:  J A Chaddock; L M Roberts; B Jungnickel; J M Lord
Journal:  Biochem Biophys Res Commun       Date:  1995-12-05       Impact factor: 3.575

4.  Shigella dysenteriae 1 cytotoxin: periplasmic protein releasable by polymyxin B and osmotic shock.

Authors:  A Donohue-Rolfe; G T Keusch
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

5.  Cloning and sequencing of a Shiga-like toxin type II variant from Escherichia coli strain responsible for edema disease of swine.

Authors:  D L Weinstein; M P Jackson; J E Samuel; R K Holmes; A D O'Brien
Journal:  J Bacteriol       Date:  1988-09       Impact factor: 3.490

6.  Orientation in lipid bilayers of a synthetic peptide representing the C-terminus of the A1 domain of shiga toxin. A polarized ATR-FTIR study.

Authors:  A Menikh; M T Saleh; J Gariépy; J M Boggs
Journal:  Biochemistry       Date:  1997-12-16       Impact factor: 3.162

7.  Characterization of monoclonal antibodies against Shiga-like toxin from Escherichia coli.

Authors:  N A Strockbine; L R Marques; R K Holmes; A D O'Brien
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

8.  Vero response to a cytotoxin of Escherichia coli.

Authors:  J Konowalchuk; J I Speirs; S Stavric
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

9.  The role of tyrosine-114 in the enzymatic activity of the Shiga-like toxin I A-chain.

Authors:  R L Deresiewicz; P R Austin; C J Hovde
Journal:  Mol Gen Genet       Date:  1993-11

10.  Crystal structure of the holotoxin from Shigella dysenteriae at 2.5 A resolution.

Authors:  M E Fraser; M M Chernaia; Y V Kozlov; M N James
Journal:  Nat Struct Biol       Date:  1994-01
View more
  9 in total

1.  Polyclonal antibodies to glutathione S-transferase--verotoxin subunit a fusion proteins neutralize verotoxins.

Authors:  P H M Leung; J S M Peiris; W W S Ng; W C Yam
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

2.  Identification of amino acids critical for the cytotoxicity of Shiga toxin 1 and 2 in Saccharomyces cerevisiae.

Authors:  Rong Di; Eric Kyu; Varsha Shete; Hemalatha Saidasan; Peter C Kahn; Nilgun E Tumer
Journal:  Toxicon       Date:  2010-12-22       Impact factor: 3.033

3.  Shiga toxin is transported from the endoplasmic reticulum following interaction with the luminal chaperone HEDJ/ERdj3.

Authors:  Min Yu; David B Haslam
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

4.  Antiviral activity of shiga toxin 1: suppression of bovine leukemia virus-related spontaneous lymphocyte proliferation.

Authors:  W A Ferens; C J Hovde
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

5.  The association of Shiga-like toxin with detergent-resistant membranes is modulated by glucosylceramide and is an essential requirement in the endoplasmic reticulum for a cytotoxic effect.

Authors:  Daniel C Smith; Daniel J Sillence; Thomas Falguières; Rosemary M Jarvis; Ludger Johannes; J Michael Lord; Frances M Platt; Lynne M Roberts
Journal:  Mol Biol Cell       Date:  2005-12-28       Impact factor: 4.138

6.  Antiviral activity of shiga toxin requires enzymatic activity and is associated with increased permeability of the target cells.

Authors:  Indira Basu; Witold A Ferens; Diana M Stone; Carolyn J Hovde
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

7.  The cholera toxin A1(3) subdomain is essential for interaction with ADP-ribosylation factor 6 and full toxic activity but is not required for translocation from the endoplasmic reticulum to the cytosol.

Authors:  Ken Teter; Michael G Jobling; Danielle Sentz; Randall K Holmes
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

8.  Modulation of toxin stability by 4-phenylbutyric acid and negatively charged phospholipids.

Authors:  Supriyo Ray; Michael Taylor; Mansfield Burlingame; Suren A Tatulian; Ken Teter
Journal:  PLoS One       Date:  2011-08-22       Impact factor: 3.240

9.  Toxin instability and its role in toxin translocation from the endoplasmic reticulum to the cytosol.

Authors:  Ken Teter
Journal:  Biomolecules       Date:  2013-12-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.